Anti-MLC1/ LVM/ MLC monoclonal antibody
Anti-MLC1/ LVM/ MLC antibody for FACS & in-vivo assay
Go to MLC1/MLC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0816-Ab-1/ GM-Tg-hg-MP0816-Ab-2 | Anti-Human MLC1 monoclonal antibody | Human |
GM-Tg-rg-MP0816-Ab-1/ GM-Tg-rg-MP0816-Ab-2 | Anti-Rat MLC1 monoclonal antibody | Rat |
GM-Tg-mg-MP0816-Ab-1/ GM-Tg-mg-MP0816-Ab-2 | Anti-Mouse MLC1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0816-Ab-1/ GM-Tg-cynog-MP0816-Ab-2 | Anti-Cynomolgus/ Rhesus macaque MLC1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0816-Ab-1/ GM-Tg-felg-MP0816-Ab-2 | Anti-Feline MLC1 monoclonal antibody | Feline |
GM-Tg-cang-MP0816-Ab-1/ GM-Tg-cang-MP0816-Ab-2 | Anti-Canine MLC1 monoclonal antibody | Canine |
GM-Tg-bovg-MP0816-Ab-1/ GM-Tg-bovg-MP0816-Ab-2 | Anti-Bovine MLC1 monoclonal antibody | Bovine |
GM-Tg-equg-MP0816-Ab-1/ GM-Tg-equg-MP0816-Ab-2 | Anti-Equine MLC1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0816-Ab-1/ GM-Tg-hg-MP0816-Ab-2; GM-Tg-rg-MP0816-Ab-1/ GM-Tg-rg-MP0816-Ab-2; GM-Tg-mg-MP0816-Ab-1/ GM-Tg-mg-MP0816-Ab-2; GM-Tg-cynog-MP0816-Ab-1/ GM-Tg-cynog-MP0816-Ab-2; GM-Tg-felg-MP0816-Ab-1/ GM-Tg-felg-MP0816-Ab-2; GM-Tg-cang-MP0816-Ab-1/ GM-Tg-cang-MP0816-Ab-2; GM-Tg-bovg-MP0816-Ab-1/ GM-Tg-bovg-MP0816-Ab-2; GM-Tg-equg-MP0816-Ab-1/ GM-Tg-equg-MP0816-Ab-2 |
Products Name | Anti-MLC1 monoclonal antibody |
Format | mab |
Target Name | MLC1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-MLC1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species MLC1/ LVM/ MLC VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLP002966 | human MLC1 Lentivirus plasmid |
ORF Viral Vector | vGMLP002966 | human MLC1 Lentivirus particle |
ORF Viral Vector | pGMLPm002794 | mouse Mlc1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002794 | mouse Mlc1 Lentivirus particle |
Target information
Target ID | GM-MP0816 |
Target Name | MLC1 |
Gene ID | 23209,170790,315215,715409,607105,101100821,618918 |
Gene Symbol and Synonyms | Kiaa0027-hp,LVM,MLC,MLC1,VL,WKL1 |
Uniprot Accession | Q15049 |
Uniprot Entry Name | MLC1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000100427 |
Target Classification | Tumor-associated antigen (TAA) |
The target: MLC1, gene name: MLC1, also named as LVM, MLC, VL. The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.